[Veco Cup] AiBo Hechuang participated in the "Veco Cup OFweek 2023 China Robotics Industry Annual Medical Robot Innovation Product Award"

The OFweek Cup 2023 China Robot Industry Annual Awards (abbreviated as OFweek Robot Awards 2023) is jointly organized by OFweek, China's high-tech industry portal, and its authoritative robot professional media - OFweek Robot. This award is a major brand event in China's robot industry and one of the most professional and influential awards in the high-tech industry.

The event aims to build a brand communication and display platform for products, technologies and companies in the robotics industry, and leverage the resources and influence of the OFweek platform to promote innovative products and solutions to industry users and the market, encouraging more companies to invest in technological innovation; at the same time, it will deliver more innovative products and cutting-edge technologies to the industry, and together imagine the future of the robotics industry.

The OFweek Robot Awards 2023, the annual selection of China's robot industry, will enter the online voting stage from February 20 to March 20, 2024, and the award ceremony will be held in Shenzhen on April 18. At present, the event is in the hot stage of enterprise application, and enterprises in the industry have responded positively.

AiBo Hechuang participated in the "Veco Cup OFweek 2023 China Robotics Industry Annual Medical Robot Innovation Product Award"

Awards: Veken Cup OFweek 2023 China Robotics Industry Annual Medical Robotics Innovation Product Award

Participating companies: Shenzhen Aibohechuang Medical Robot Co., Ltd.

Product Introduction:

AIBO Pan-vascular Interventional Surgery Robot

The vascular interventional surgical robot system is the core product of Aibo Hechuang. It is suitable for three types of surgeries: percutaneous coronary intervention (PCI), peripheral vascular intervention (PVI) and neurointervention (NVI), and can match various standardized guidewire catheters on the market.

Company Introduction:

Shenzhen Aibo Hechuang Medical Robot Co., Ltd. (abbreviated as Aibo Hechuang) is a high-tech medical robot company founded by Professor Guo Shuxiang, an expert in the overseas high-level talent introduction program, a foreign academician of the Japan Academy of Engineering, and an IEEE Fellow, and his team. Aibo Medical Robotics is deeply engaged in the field of vascular interventional surgical robots. Adhering to the values ​​of "user first, pursuit of excellence, innovation-driven, and agile iteration", it creates a vascular interventional surgical control system that is easy for surgeons to use and beneficial for patients and has completely independent intellectual property rights. It is committed to becoming a respected global leader in vascular interventional surgical robots. As of December 2023, the company has applied for more than 450 intellectual property rights such as Chinese invention patents and international patents, and many original technologies have reached the international leading level. The company has reached cooperation with a well-known domestic team of clinical experts in the field of vascular intervention, and has received investment from a number of first-line investment institutions.

Reasons for participation:

As of now, as the pioneer of the world's first pan-vascular interventional surgical robot, Aibo Medical Robotics has always adhered to the user-centric and demand-oriented approach, using advanced design thinking and integrated new product development (iNPD) and other concepts and methods to implant the concept of medical and engineering integration into the entire life cycle of innovative product development, and has become a leader in China's pan-vascular interventional surgical robot field.

Aibohechuang works closely with the Key Laboratory of Integrated Medical-Engineering Systems and Health Engineering of the Ministry of Industry and Information Technology, the Medical and Health Robotics Laboratory of Kagawa University in Japan, the Intelligent Robotics Laboratory of Tianjin University of Technology and other top domestic and foreign technical R&D teams to enhance the company's R&D capabilities and reserve excellent R&D talents.

Aibohechuang has established in-depth cooperation with top domestic tertiary hospitals such as the PLA Navy General Hospital, Beijing Tiantan Hospital and the Third Medical Center of the PLA, and invited top domestic medical experts in the field of vascular intervention to join the R&D team. It collaborates with top integrated innovation and design experts to continuously explore the clinical needs of doctors during patients' vascular interventional treatment, continuously improve the operating accuracy of surgical robot systems, and continuously iterate products.

Voting time:

The voting for this year's "OFweek Robot Awards 2023" event will begin on February 20. Please pay attention to the robot-related selection news on Veken.com and you are welcome to vote.